U.S. patent agency to decide inventor of powerful gene editing technology

NEW YORK (Reuters) - A showdown between two teams of top U.S. scientists over who was first to invent a breakthrough gene-editing technology known as CRISPR formally began on Monday as a U.S. government agency launched proceedings to decide the issue.